BAK - Braskem S.A.
NYSE
->
Basic Materials
->
Chemicals
Camaçari,
Brazil
Type: Equity
BAK price evolution
BAK
| (in millions $) | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5122 | $6445 | ||
| Short term investments | ||||
| Net receivables | $5959 | $5505 | ||
| Inventory | $12476 | $12985 | ||
| Total current assets | $37276 | $34339 | ||
| Long term investments | ||||
| Property, plant & equipment | $42119 | $41591 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $92015 | $88009 | ||
| Current liabilities | ||||
| Accounts payable | $13278 | $11963 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $24180 | $23112 | ||
| Long term debt | $54083 | $48229 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $86993 | $80777 | ||
| Shareholders' equity | ||||
| Retained earnings | -$1167 | $1249 | ||
| Other shareholder equity | -$1876 | -$2077 | ||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6074.21 | $8680.69 | $13862.85 | |
| Short term investments | $106.27 | $3627.23 | ||
| Net receivables | $5507.72 | $9772.03 | $7937.88 | |
| Inventory | $14030.06 | $16335.1 | $8383.65 | |
| Total current assets | $34457.66 | $39293.44 | $34190.24 | |
| Long term investments | $58.92 | $58.72 | ||
| Property, plant & equipment | $41716.28 | $40005.17 | $38831.54 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $10067.37 | |||
| Total investments | ||||
| Total assets | $88048.86 | $92564.37 | $86083.92 | |
| Current liabilities | ||||
| Accounts payable | $12246.78 | $12053.27 | $9946.32 | |
| Deferred revenue | ||||
| Short long term debt | $1489.35 | $9928.6 | ||
| Total current liabilities | $24185.25 | $25193.52 | $28387.17 | |
| Long term debt | $48036.89 | $49562.9 | $47306.76 | |
| Total noncurrent liabilities | $11943.27 | |||
| Total debt | ||||
| Total liabilities | $80727.06 | $86360.54 | $88286.23 | |
| Shareholders' equity | ||||
| Retained earnings | $1831.79 | $3483.93 | -$4529.55 | |
| Other shareholder equity | -$2525.04 | -$3623.14 | -$5666.28 | |
| Total shareholder equity | $7865.82 | -$2202.31 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 30 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $105625.2 | $58543.49 | $52323.53 | |
| Cost of revenue | $73595.14 | $47331.41 | $45679.5 | |
| Gross Profit | $32030.06 | $11212.08 | $6644.02 | |
| Operating activities | ||||
| Research & development | $296.58 | $250.65 | $247.73 | |
| Selling, general & administrative | $4577.77 | $3296.24 | $2107.4 | |
| Total operating expenses | $78286.89 | $58615.39 | $52380.1 | |
| Operating income | $27338.31 | -$71.89 | -$56.58 | |
| Income from continuing operations | ||||
| EBIT | $27338.31 | |||
| Income tax expense | $3999.4 | -$2668.48 | -$1906 | |
| Interest expense | -$3787.74 | $19.4 | -$10.22 | |
| Net income | ||||
| Net income | $13984.95 | -$6691.72 | -$2797.57 | |
| Income (for common shares) | $13984.95 | -$6691.72 | -$2797.57 | |
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3017 | -$1793 | -$924.89 | -$4947.27 |
| Financing activities | ||||
| Dividends paid | -$7 | -$3 | -$0.14 | -$1350.29 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $7714 | $3778 | $3716.61 | $225.09 |
| Effect of exchange rate | -$241 | -$389 | -$73.19 | -$443.77 |
| Change in cash and equivalents | $1170 | $774 | -$83.31 | $3785.79 |
| (in millions $) | 31 Jan 2023 | 30 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $13984.95 | -$9683.78 | -$4802.97 | |
| Operating activities | ||||
| Depreciation | $4114.43 | $4048.08 | $3632.26 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $14786.49 | $6292.99 | $2265.28 | |
| Investing activities | ||||
| Capital expenditures | -$3421.32 | -$2759.79 | -$2682.52 | |
| Investments | ||||
| Total cash flows from investing | -$4947.27 | -$3380.68 | -$2721.83 | -$2666.42 |
| Financing activities | ||||
| Dividends paid | -$1350.29 | -$5993.27 | -$2.38 | -$668.9 |
| Sale and purchase of stock | ||||
| Net borrowings | -$10962.69 | $2747.68 | $1805.67 | |
| Total cash flows from financing | $225.09 | -$16965.5 | $2173.22 | $1636.77 |
| Effect of exchange rate | -$443.77 | $377.53 | $1314.59 | $20.62 |
| Change in cash and equivalents | $3785.79 | -$5182.17 | $7058.97 | $1256.24 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |